Letellier Pharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Letellier Pharma
Largest movements
- Financial fixed assets -€555,300
down €555,300 (-30.0%), from €1.9m to €1.3m
- Cash +€418,008
up €418,008 (+2,206%), from €18,948 to €436,956
mainly Investment in fixed assets (net) (+€550,366) and Net result for the year (+€139,809)
- Receivables within one year +€111,378
up €111,378 (+19,629%), from €567 to €111,946
of which Trade receivables: +€111,946
- Receivables after one year +€84,000
new in 2025: €84,000
- Tangible fixed assets -€38,269
down €38,269 (-3.3%), from €1.1m to €1.1m
of which Land and buildings: -€26,477
- Debts after one year -€178,365
down €178,365 (-13.7%), from €1.3m to €1.1m
- Profit (loss) carried forward +€139,809
up €139,809 (+25.4%), from €551,006 to €690,815
- Other debts +€89,062
up €89,062 (+111%), from €80,564 to €169,625
- Reserves -€45,000
down €45,000 (-5.5%), from €820,519 to €775,519
- Tax, wage and social debts +€40,365
up €40,365 (+146%), from €27,669 to €68,034
- Gross operating margin +€31,483
up €31,483 (+12.3%), from €255,213 to €286,695
- Taxes +€15,031
up €15,031 (+38.1%), from €39,433 to €54,463
- Financial charges +€14,521
up €14,521 (+44.7%), from €32,522 to €47,043
of which Non-recurring financial charges: +€21,300
- Other operating charges -€5,601
down €5,601 (-72.0%), from €7,777 to €2,176
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €3,025,386 | €3,043,227 | +€17,842 | +0.6% |
| Fixed assets | 21/28 | €2,999,079 | €2,405,510 | -€593,569 | -19.8% |
| Tangible fixed assets | 22/27 | €1,148,947 | €1,110,677 | -€38,269 | -3.3% |
| Land and buildings | 22 | €1,067,119 | €1,040,641 | -€26,477 | -2.5% |
| Plant, machinery and equipment | 23 | €40,241 | €37,827 | -€2,414 | -6.0% |
| Leasing and similar rights | 25 | €41,587 | €30,209 | -€11,378 | -27.4% |
| Other tangible fixed assets | 26 | - | €2,000 | +€2,000 | |
| Financial fixed assets | 28 | €1,850,132 | €1,294,833 | -€555,300 | -30.0% |
| Current assets | 29/58 | €26,306 | €637,717 | +€611,411 | +2,324% |
| Amounts receivable after more than one year | 29 | - | €84,000 | +€84,000 | |
| Trade receivables | 290 | - | €84,000 | +€84,000 | |
| Amounts receivable within one year | 40/41 | €567 | €111,946 | +€111,378 | +19,629% |
| Trade receivables | 40 | - | €111,946 | +€111,946 | |
| Other amounts receivable | 41 | €567 | - | -€567 | |
| Cash at bank and in hand | 54/58 | €18,948 | €436,956 | +€418,008 | +2,206% |
| Deferred charges and accrued income | 490/1 | €6,791 | €4,815 | -€1,975 | -29.1% |
| Total equity and liabilities | 10/49 | €3,025,386 | €3,043,227 | +€17,842 | +0.6% |
| Equity | 10/15 | €1,396,525 | €1,491,334 | +€94,809 | +6.8% |
| Contributions | 10/11 | €25,000 | €25,000 | = | 0.0% |
| Reserves | 13 | €820,519 | €775,519 | -€45,000 | -5.5% |
| Distributable reserves | 133 | €820,519 | €775,519 | -€45,000 | -5.5% |
| Profit (loss) carried forward | 14 | €551,006 | €690,815 | +€139,809 | +25.4% |
| Amounts payable | 17/49 | €1,628,861 | €1,551,893 | -€76,968 | -4.7% |
| Amounts payable after more than one year | 17 | €1,297,343 | €1,118,978 | -€178,365 | -13.7% |
| Financial debts | 170/4 | €1,297,343 | €1,118,978 | -€178,365 | -13.7% |
| Amounts payable within one year | 42/48 | €326,602 | €425,735 | +€99,133 | +30.4% |
| Current portion of amounts payable after more than one year | 42 | €179,232 | €185,298 | +€6,066 | +3.4% |
| Financial debts | 43 | €23,521 | - | -€23,521 | |
| Credit institutions | 430/8 | €23,521 | - | -€23,521 | |
| Trade debts | 44 | €15,616 | €2,778 | -€12,838 | -82.2% |
| Suppliers | 440/4 | €15,616 | €2,778 | -€12,838 | -82.2% |
| Taxes, remuneration and social security | 45 | €27,669 | €68,034 | +€40,365 | +146% |
| Taxes | 450/3 | €27,669 | €68,034 | +€40,365 | +146% |
| Other amounts payable | 47/48 | €80,564 | €169,625 | +€89,062 | +111% |
| Accrued charges and deferred income | 492/3 | €4,915 | €7,180 | +€2,265 | +46.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €41,450 | €43,203 | +€1,754 | +4.2% |
| Other operating charges | 640/8 | €7,777 | €2,176 | -€5,601 | -72.0% |
| Gross operating margin | 9900 | €255,213 | €286,695 | +€31,483 | +12.3% |
| Operating profit (loss) | 9901 | €205,986 | €241,316 | +€35,330 | +17.2% |
| Financial income | 75/76B | €1 | - | -€1 | |
| Recurring financial income | 75 | €1 | - | -€1 | |
| Financial charges | 65/66B | €32,522 | €47,043 | +€14,521 | +44.7% |
| Recurring financial charges | 65 | €32,522 | €25,744 | -€6,779 | -20.8% |
| Non-recurring financial charges | 66B | - | €21,300 | +€21,300 | |
| Profit (loss) for the period before taxes | 9903 | €173,465 | €194,273 | +€20,808 | +12.0% |
| Income taxes | 67/77 | €39,433 | €54,463 | +€15,031 | +38.1% |
| Profit (loss) for the period | 9904 | €134,033 | €139,809 | +€5,777 | +4.3% |
| Profit (loss) for the period to be appropriated | 9905 | €134,033 | €139,809 | +€5,777 | +4.3% |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.